Cargando…
Modulating Th2 Cell Immunity for the Treatment of Asthma
It is estimated that more than 339 million people worldwide suffer from asthma. The leading cause of asthma development is the breakdown of immune tolerance to inhaled allergens, prompting the immune system's aberrant activation. During the early phase, also known as the sensitization phase, al...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902894/ https://www.ncbi.nlm.nih.gov/pubmed/33643321 http://dx.doi.org/10.3389/fimmu.2021.637948 |